Moreover, theoretically, SGLT-2 inhibitors may prompt dehydration, because they raise the overall risk of fractures by causing osmotic diuresis, intravascular volume contraction, orthostatic hypotension, and an increased risk of falls (46). The gene discussed is SLC5A2; the disease is orthostatic hypotension.